News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Vectus Biosystems.
RELATED STOCKHEAD STORIES
News
LAST ORDERS: A short treatise on the cavalcade of whimsy from the ASX and elsewhere today
Health & Biotech
ASX Health Stocks: Biotron expands COVID-19 study in Thailand; Noxopharm, Clarity progress pancreatic cancer research
News
ASX Small Cap Lunch Wrap: Who’s over making the worst possible moves?
Health & Biotech
ASX Health Stocks: Vectus jumps 13pc on promising Phase 1 study results
News
Trading Places: Who’s already playing the BNPL hunger games?
Health & Biotech
ASX Health Stocks: Genetic Tech is now lab certified and begins rollout of its geneType Multi-Test
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
Health & Biotech
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
News
Weekly ASX small cap wrap: Who’s taking over the skies?
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Last Orders: What you might have missed on the ASX today
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: When don’t you want to reveal a $1.3m deal? When it’s not selling COVID cures to China
Health & Biotech
